We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
CLNB 2026: Suzhou Hosts Premier Global New Energy Expo This April
about 4 hours ago
Latin America's Lithium Boom: $3B+ Projects Revealed in New Report
about 5 hours ago
Nicola Mining Boosts Gold-Silver Throughput, Eyes NASDAQ Uplisting
about 5 hours ago
Realay Debuts Voice AI Platform at Independent Broker Conference
about 6 hours ago
HR News
Fractional HR: Texas's Answer to Growth & Compliance Risks
1 day ago
HR.com Honors Top CHROs and Women Leaders in 2026 Awards
1 day ago
Galaxy Payroll Renews 5-Year Strategic Deal with Nike Macau
2 days ago
Trilogy Metals Bolsters Ambler Metals Leadership for Alaska Copper Project
3 days ago
Survale Workshop Unlocks Hiring Secrets in Philadelphia
8 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
South African Wellness Brand The Harvest Table Expands to U.S. via OneLavi.com
about 3 hours ago
Knightscope Surpasses $2M in Sales with Security Robots and Emergency Devices
about 4 hours ago
Crypto News
Bitcoin Drops 5% as Trump Tariff Announcement Spooks Crypto Markets
about 7 hours ago
Datavault AI Powers Dream Bowl 2026's First Meme Coin in Web3 Sports Partnership
2 days ago
Argentina Opens Doors for Mattress Money to Flow Into Crypto
2 days ago
JPMorgan Crowns XRP as Banks' Go-To Crypto in Confidential Briefing
2 days ago
Datavault AI Reschedules Dividend Distribution for Warrants and Meme Coin Tokens
3 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
Ketryx Hits Record Momentum as AI Compliance Platform Serves 100M+ Patients
about 4 hours ago
Soligenix's SGX945 Gains EU Orphan Drug Recommendation for Behçet Disease
about 6 hours ago
Technology News
Knightscope Surpasses $2M in Sales with Security Robots and Emergency Devices
about 4 hours ago
VectorCertain Exposes 97% AI Safety Gap as Autonomous Agents Attack Humans
about 5 hours ago
Safe Pro Group Demonstrates AI Defense Tech at Army's Autonomous Breach Event
about 5 hours ago
Nightfood Robotics Featured in AI Industry Evolution Report
about 6 hours ago
NextPlat Expands Satellite Services to 5 South American Markets via Mercado Libre
about 6 hours ago
Events & Conferences
CLNB 2026: Suzhou Hosts Premier Global New Energy Expo This April
about 4 hours ago
Latin America's Lithium Boom: $3B+ Projects Revealed in New Report
about 5 hours ago
Vostock Capital Reveals Key Latin American Lithium Projects Ahead of 2026 Congress
about 5 hours ago
Realay Debuts Voice AI Platform at Independent Broker Conference
about 6 hours ago
NeuroOne to Host Virtual Investor Webinar on March 12, 2026
about 7 hours ago